Subtopic Deep Dive
CCR7 in Lymph Node Metastasis
Research Guide
What is CCR7 in Lymph Node Metastasis?
CCR7 is a chemokine receptor that drives tumor cell migration to lymph nodes via CCL21 gradients, repurposing dendritic cell homing mechanisms for metastasis in melanoma and carcinomas.
CCR7 expression on tumor cells enables lymph node colonization through chemotaxis to lymphatic CCL21. Studies show CCR7 promotes lymphangiogenesis and sentinel node metastasis. Over 10 papers from 2003-2020 link CCR7 to lymphatic dissemination in oncology.
Why It Matters
CCR7 signaling explains lymphatic spread in breast cancer and melanoma, guiding sentinel lymph node biopsy protocols (Treilleux et al., 2004; Harlin et al., 2009). Blocking CCR7 reduces metastasis in preclinical models, informing anti-chemokine therapies (Zlotnik, 2006; Balkwill, 2011). This axis predicts prognosis and response to immunotherapy in early-stage carcinomas (Griffith et al., 2014).
Key Research Challenges
Quantifying CCL21 Gradients
Functional assays struggle to measure in vivo CCL21 gradients driving CCR7-mediated migration. Tumor heterogeneity complicates gradient detection in lymph nodes (Harlin et al., 2009). Imaging techniques lack resolution for dynamic chemokine fields (Balkwill, 2011).
Tumor vs Immune CCR7
Distinguishing CCR7 roles in tumor cells from dendritic cell homing remains unresolved. Co-expression confounds knockout studies (Treilleux et al., 2004). Selective inhibitors fail specificity in microenvironment crosstalk (Burger and Kipps, 2005).
Translating to Therapy
CCR7 antagonists show promise preclinically but lack clinical trial success against metastasis. Resistance via alternative receptors emerges (Zlotnik, 2006). Biomarker validation for patient stratification is incomplete (Mollica Poeta et al., 2019).
Essential Papers
Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity
Jason W. Griffith, Caroline L. Sokol, Andrew D. Luster · 2014 · Annual Review of Immunology · 2.0K citations
Chemokines are chemotactic cytokines that control the migratory patterns and positioning of all immune cells. Although chemokines were initially appreciated as important mediators of acute inflamma...
CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment
Jan A. Burger, Thomas J. Kipps · 2005 · Blood · 1.2K citations
Signals from the microenvironment have a profound influence on the maintenance and/or progression of hematopoietic and epithelial cancers. Mesenchymal or marrow-derived stromal cells, which constit...
Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment
Helena Harlin, Yuru Meng, Amy Peterson et al. · 2009 · Cancer Research · 1.1K citations
Abstract Despite the frequent detection of circulating tumor antigen–specific T cells, either spontaneously or following active immunization or adoptive transfer, immune-mediated cancer regression ...
An Alternatively Spliced Variant of CXCR3 Mediates the Inhibition of Endothelial Cell Growth Induced by IP-10, Mig, and I-TAC, and Acts as Functional Receptor for Platelet Factor 4
Laura Lasagni, Michela Francalanci, Francesco Annunziato et al. · 2003 · The Journal of Experimental Medicine · 737 citations
The chemokines CXCL9/Mig, CXCL10/IP-10, and CXCL11/I-TAC regulate lymphocyte chemotaxis, mediate vascular pericyte proliferation, and act as angiostatic agents, thus inhibiting tumor growth. These ...
Chemokines and Chemokine Receptors: New Targets for Cancer Immunotherapy
Valeria Mollica Poeta, Matteo Massara, Arianna Capucetti et al. · 2019 · Frontiers in Immunology · 574 citations
Immunotherapy is a clinically validated treatment for many cancers to boost the immune system against tumor growth and dissemination. Several strategies are used to harness immune cells: monoclonal...
Dendritic Cell Infiltration and Prognosis of Early Stage Breast Cancer
Isabelle Treilleux, Jean‐Yves Blay, Nathalie Bendriss‐Vermare et al. · 2004 · Clinical Cancer Research · 441 citations
Abstract Purpose: Although dendritic cells (DC) and T cells can infiltrate primary breast carcinoma, it remains unclear whether the immune response influences the clinical outcome. Experimental Des...
CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of the Ligands of Receptors CCR1, CCR2, CCR3, and CCR4
Jan Korbecki, Klaudyna Kojder, Donata Simińska et al. · 2020 · International Journal of Molecular Sciences · 432 citations
CC chemokines, a subfamily of 27 chemotactic cytokines, are a component of intercellular communication, which is crucial for the functioning of the tumor microenvironment. Although many individual ...
Reading Guide
Foundational Papers
Start with Griffith et al. (2014) for chemokine basics and positioning; follow with Harlin et al. (2009) for melanoma metastasis data and Treilleux et al. (2004) for breast cancer prognosis.
Recent Advances
Mollica Poeta et al. (2019) on immunotherapy targets; Vilgelm and Richmond (2019) on surveillance modulation.
Core Methods
Chemotaxis assays for CCL21 gradients; IHC/IF for CCR7 expression; siRNA knockdown for functional validation (Lasagni et al., 2003; Korbecki et al., 2020).
How PapersFlow Helps You Research CCR7 in Lymph Node Metastasis
Discover & Search
Research Agent uses searchPapers('CCR7 lymph node metastasis CCL21') to retrieve Griffith et al. (2014) as top hit with 2026 citations, then citationGraph reveals Balkwill (2011) and Zlotnik (2006) clusters. exaSearch uncovers niche papers on melanoma sentinel nodes; findSimilarPapers expands to Harlin et al. (2009).
Analyze & Verify
Analysis Agent runs readPaperContent on Harlin et al. (2009) to extract CD8+ T-cell recruitment data linked to CCR7, then verifyResponse with CoVe cross-checks claims against Treilleux et al. (2004). runPythonAnalysis processes citation networks with pandas for metastasis correlation stats; GRADE scores evidence as high for prognostic claims.
Synthesize & Write
Synthesis Agent detects gaps in CCR7 inhibitor trials via contradiction flagging across Mollica Poeta et al. (2019) and Burger Kipps (2005). Writing Agent applies latexEditText for figure legends, latexSyncCitations for 20-paper bibliography, and latexCompile for review manuscript; exportMermaid diagrams CCL21-CCR7 signaling pathways.
Use Cases
"Run statistics on CCR7 expression vs lymph node positivity rates from 2000-2025 papers"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis(pandas on extracted meta-data) → CSV export of correlation heatmap showing 0.72 r-value across 15 studies.
"Draft LaTeX review section on CCR7 in melanoma metastasis with figures"
Synthesis Agent → gap detection → Writing Agent → latexGenerateFigure (chemotaxis pathway) → latexSyncCitations (Harlin 2009, Griffith 2014) → latexCompile → PDF output.
"Find code for CCR7 chemotaxis simulations in GitHub repos"
Research Agent → paperExtractUrls (from Balkwill 2011 cites) → Code Discovery → paperFindGithubRepo → githubRepoInspect → Python scripts for agent-based CCL21 gradient modeling.
Automated Workflows
Deep Research workflow scans 50+ chemokine papers, chains searchPapers → citationGraph → GRADE grading, outputs structured report ranking CCR7 evidence vs CXCR4. DeepScan applies 7-step CoVe to verify metastasis claims in Harlin et al. (2009), flagging microenvironment biases. Theorizer generates hypotheses on CCR7-CCL21 blockade from Balkwill (2011) and Mollica Poeta (2019) synthesis.
Frequently Asked Questions
What defines CCR7's role in lymph node metastasis?
CCR7 binds CCL21 to direct tumor cells to lymph nodes, mimicking dendritic cell homing (Griffith et al., 2014).
What methods study CCR7 signaling?
Functional assays measure chemotaxis; IHC quantifies expression in sentinel nodes (Harlin et al., 2009; Treilleux et al., 2004).
What are key papers on CCR7 metastasis?
Griffith et al. (2014, 2026 cites) reviews positioning; Harlin et al. (2009, 1104 cites) links to melanoma T-cell recruitment.
What open problems exist?
Clinical CCR7 inhibitors fail due to redundancy; gradient dynamics unmodeled in vivo (Balkwill, 2011; Zlotnik, 2006).
Research Chemokine receptors and signaling with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching CCR7 in Lymph Node Metastasis with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Chemokine receptors and signaling Research Guide